Wiener lab Group
Wiener lab Group is the largest in vitro diagnostic company in Latin America, providing instruments, reagents, and laboratory software to clinical-analysis labs across more than 50 countries from its Argentine base.
- Company typePrivate
- Founded1960
- HeadquartersRosario, Argentina
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Wiener lab Group does
Wiener lab Group operates as the largest in vitro diagnostic (IVD) company in Latin America, headquartered in Argentina with more than 60 years of operational history. It develops, manufactures, and distributes diagnostic products and services for clinical analysis laboratories, serving hospital, clinic, and reference-lab customers across more than 50 countries. Its portfolio of 500+ solutions is organized into three product layers: instruments (laboratory automation hardware), reagents (clinical chemistry, immunoassay, hematology, and related diagnostic consumables), and tailor-made software for laboratory information management and workflow.
The company runs four dedicated R&D+i (research, development, and innovation) centers staffed by an interdisciplinary team, and pursues a horizontal IVD strategy addressing multiple analytical disciplines rather than specialization in a single assay category. This structure enables cross-platform reagent development and integrated instrument-software bundles. Distribution is hybrid: direct sales and service in core markets, supplemented by a network of authorized distributors in secondary international geographies. The underlying business model follows the classic razor-and-blade economics of the IVD sector — capital equipment placements generate an installed base that pulls through recurring, higher-margin reagent and consumable revenue, while software deepens account stickiness.
Wiener lab is privately held; no funding rounds, M&A activity, or leadership transitions are disclosed in the available input. Operational evidence — sustained international distribution, a 500+ SKU portfolio, four R&D centers, and an active 2026 events calendar — points to a mature, steady-state business rather than a high-growth or turnaround profile. The principal data gaps are quantitative: no revenue, headcount, growth-rate, or customer-concentration disclosures are available, which limits confidence on financial trajectory.
Wiener lab Group firmographics
Firmographics- Name
- Wiener lab Group
- Legal name
- Wiener Laboratorios SAIC
- Website
- https://wiener-lab.com.ar
- Company type
- Private
- Founded year
- 1960
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Wiener lab Group is the largest in vitro diagnostic company in Latin America, providing instruments, reagents, and laboratory software to clinical-analysis labs across more than 50 countries from its Argentine base.
- Ownership category
- akta.pro rank
Wiener lab Group industry classification
Industry- Product category
- In Vitro Diagnostics
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
- akta.pro secondary industries
- Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity) (HLAHAAAO), Maintenance, Service Contracts & Equipment Repair (Field Service, Parts) (HLAGAIAN)
Keywords
Where Wiener lab Group is headquartered
LocationHeadquarters
- HQ city
- Rosario
- HQ country
- Argentina
- HQ region
- Latin America
Offices1 record
Markets served
Wiener lab Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Instrument Sales: Sale of clinical analysis instruments and automation equipment to laboratories. Equipment sales represent a significant revenue stream with typically higher transaction values and longer sales cycles associated with enterprise laboratory clients.
- Reagent Sales: Sale of diagnostic reagents and consumables required for clinical testing. Reagent sales provide recurring revenue as laboratories require ongoing supply for continuous diagnostic operations.
- Software Solutions: Sale and licensing of tailor-made IT software solutions for laboratory information management and diagnostic workflow optimization.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Wiener lab Group product offering
Product offeringCore offering
Wiener lab Group is the largest in vitro diagnostic company in Latin America, selling a comprehensive portfolio of more than 500 diagnostic solutions to clinical analysis laboratories. Its offering comprises three core product lines: clinical analysis Instruments (laboratory automation equipment), Reagents (innovative and affordable diagnostic reagent systems), and tailor-made Software (IT solutions for laboratory information management and workflow optimization). The company also provides permanent technical customer support delivered by an interdisciplinary team of biochemists, engineers and technicians.
Product overview
Wiener lab Group is the largest in vitro diagnostic company in Latin America, offering a unified platform of diagnostic solutions comprising three core product lines: Instruments (laboratory automation equipment), Reagents (diagnostic systems), and Software (IT solutions). Together, these products provide comprehensive solutions for clinical analysis laboratories of various sizes, spanning over 500 diagnostic solutions across more than 50 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Instruments Wide range of laboratory equipment designed to automate clinical analysis laboratories of various sizes, providing comprehensive solutions for laboratory automation and clinical analysis workflows. Targeted at clinical analysis laboratories ranging from small standalone labs to large hospital laboratories.
- Reagents Innovative, reliable, and affordable diagnostic reagent systems used for in vitro diagnostics, forming a core component of the company's diagnostic solution portfolio and providing recurring consumables for clinical laboratories.
- Software Tailor-made IT solutions designed to complement the diagnostic instruments and reagents, providing integrated information technology support for laboratory information management and diagnostic workflow optimization.
Companies that use Wiener lab Group
Customer profileSegments1 record
Ideal customer profiles1 record
Wiener lab Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Wiener lab Group partnerships and signals
Strategic signalScale indicators4 records
Recent moves3 records
Expansion highlights2 records
Wiener lab Group competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Diversified life science and clinical diagnostics company with a clinical IVD portfolio in immunology, blood typing, and QC materials. Comparable in selling reagents and instruments to clinical analysis labs and in emerging-market distribution.
- DiaSorin: Specialty IVD company with a focused reagent and instrument menu (LIAISON) in clinical chemistry and immunoassays. Comparable in scale, vertically integrated model, and reliance on recurring reagent revenue from clinical labs.
- bioMérieux: Specialty IVD company focused on microbiology, immunoassays, and clinical chemistry with strong emerging-market presence. Closely comparable business model (instruments + reagents, recurring consumables) and similar target of mid-sized clinical labs in developing markets.
- Erba Mannheim: Mid-sized IVD company offering clinical chemistry, hematology, and immunoassay instruments and reagents with strong emerging-market focus. Closely comparable in scale, product mix, and pricing-oriented positioning against global giants.
Broad incumbents
- Beckman Coulter (Danaher): Global IVD player in clinical chemistry, immunoassay, and hematology with strong mid-tier lab presence. Comparable in customer segment, instrument-reagent model, and competition for hospital and reference lab contracts in the region.
- Siemens Healthineers: Major IVD and diagnostics informatics provider (Atellica, ADVIA Centaur). Comparable as a full-stack instruments + reagents + LIS competitor in mid- and large-sized hospital laboratories across Latin America.
- Sysmex: Global IVD leader in hematology and urinalysis with expanding clinical chemistry offerings. Comparable in instruments + reagents model and in competing for routine testing workloads in hospital and reference labs.
- Roche Diagnostics: Global IVD leader with the broadest integrated instruments/reagents/software portfolio (cobas, Elecsys, etc.). Comparable as the benchmark integrated IVD player that Wiener lab competes against, especially in Latin American hospital labs.
- Abbott Diagnostics: Global IVD incumbent with ARCHITECT and Alinity platforms spanning clinical chemistry and immunoassays. Directly comparable in product mix and target customer (clinical analysis labs) and a key competitor across LatAm.
Emerging players
- Mindray: Fast-growing Chinese IVD and medical device manufacturer with an aggressive push into Latin America and emerging markets. Directly comparable in targeting mid-tier labs with cost-competitive instruments and reagents.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Wiener lab Group social profiles
Digital presenceWiener lab Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Wiener lab Group leadership team
Management profileNumber of profiles
Wiener lab Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Wiener lab Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Wiener lab Group
What does Wiener lab Group do?
Wiener lab Group is the largest in vitro diagnostic company in Latin America, selling a comprehensive portfolio of more than 500 diagnostic solutions to clinical analysis laboratories. Its offering comprises three core product lines: clinical analysis Instruments (laboratory automation equipment), Reagents (innovative and affordable diagnostic reagent systems), and tailor-made Software (IT solutions for laboratory information management and workflow optimization). The company also provides permanent technical customer support delivered by an interdisciplinary team of biochemists, engineers and technicians.
Is Wiener lab Group a public or private company?
Wiener lab Group is a private company. It is classified as unknown and is currently operating.
When was Wiener lab Group founded?
Wiener lab Group was founded in 1960. It employs 501 to 1,000 people.
Where is Wiener lab Group based?
Wiener lab Group is headquartered in Rosario, Argentina, in the Latin America region.
How does Wiener lab Group make money?
Three revenue lines are on record. Instrument Sales are the primary driver. The others are reagent Sales and software Solutions.
Who are Wiener lab Group's main competitors?
Direct peers on record are Bio-Rad Laboratories, DiaSorin, bioMérieux and Erba Mannheim. Broad incumbents are Beckman Coulter (Danaher), Siemens Healthineers, Sysmex, Roche Diagnostics and Abbott Diagnostics. Mindray is listed as an emerging player.
Does Wiener lab Group have an API?
No public API is recorded for Wiener lab Group.
What industry is Wiener lab Group in?
Wiener lab Group's product category is In Vitro Diagnostics. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAHAAAO, Laboratory Informatics for Diagnostics (LIS/Middleware/Analyzer Connectivity). Its NAICS code is 334516 and its SIC code is 3826.